MedPath

Effect of Orthokeratology Versus Spectacles on Myopia Progression in Chinese Children: A Crossover Trial

Phase 4
Completed
Conditions
Myopia
Registration Number
NCT02186184
Lead Sponsor
Beijing Tongren Hospital
Brief Summary

Orthokeratology is becoming popular for the treatment of myopia children. Many studies have shown that orthokeratology is effective in temporarily reducing refractive error, and is also helpful for controlling myopia progression. However, the mechanism for its slowing myopia progression and rebound effect after the treatment have not been clearly studied. In addition, the effect of orthokeratology among Chinese children has not been evaluated with randomized controlled trial.This study is to assess the effect of orthokeratology versus spectacles on myopia progression in school-aged Chinese children during two years.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Ages Eligible for Study: 7 Years to 14 Years
  • Genders Eligible for Study: Both
  • Visual acuity 20/20 or better in each eye
  • Spherical error ranging from -0.5 D to -5.0 D and astigmatism less than 1.5 D in each eye, anisometropia less than 1.0 D between the two eyes
  • No strabismus, amblyopia and any other ocular or systematic diseases that may affect refractive development
Exclusion Criteria
  • Currently or history using other interventions to control myopia progression (acupuncture, drugs, contact lens, ear needles and so on)
  • Unable to cooperate with the ocular examination,questionnaire survey,or orthokeratology wearing

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Axial lengthChange from baseline at 2 years
RefractionChange from baseline at 2 years
Secondary Outcome Measures
NameTimeMethod
Tear film break up time(BUT)Change from baseline at 2 years
Self evaluation of comfortablenessChange from baseline at 1 year
Corneal endothelial cell densityChange from baseline at 2 years
Self evaluation of comfortnessChange from baseline at 2 years

Trial Locations

Locations (1)

Beijing Tongren Hospital

🇨🇳

Beijing, Beijing, China

Beijing Tongren Hospital
🇨🇳Beijing, Beijing, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.